BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 815169)

  • 1. Cleavage products of C4b produced by enzymes in human serum.
    Shiraishi S; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):935-9. PubMed ID: 815169
    [No Abstract]   [Full Text] [Related]  

  • 2. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 3. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of human complement subcomponent C4. C4 cleavage by C1s.
    Reboul A; Thielens N; Villiers MB; Colomb MG
    FEBS Lett; 1979 Jul; 103(1):156-61. PubMed ID: 467643
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M; Ono Y
    Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):172-6. PubMed ID: 1171606
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of reduction and reoxidation on the biological activities and structure of human Clq (first component of complement).
    Heusser CH; Boesman M; Knobel HR; Jacot-Guillarmod H; Isliker H
    Immunochemistry; 1975 Mar; 12(3):213-9. PubMed ID: 811542
    [No Abstract]   [Full Text] [Related]  

  • 9. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemistry and immunobiology of the complement system.
    Gigli I
    J Invest Dermatol; 1976 Sep; 67(3):346-53. PubMed ID: 787430
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between complement component C4b-binding protein and the vitamin K-dependent protein S. A link between blood coagulation and the complement system.
    Dahlbäck B
    Scand J Clin Lab Invest Suppl; 1985; 177():33-41. PubMed ID: 2933802
    [No Abstract]   [Full Text] [Related]  

  • 13. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels and glomerular deposits of some components of complement in glomerular diseases. Correlations in 172 cases].
    Rovati C; Barbiano di Belgiojoso G; Durante A; Minetti L
    Minerva Nefrol; 1975; 22(6):252-61. PubMed ID: 1223702
    [No Abstract]   [Full Text] [Related]  

  • 20. Function of the activated fourth component of complement (C4b) in activation of C2.
    Vogt W; Hinsch B; Schmidt G; von Zabern I
    FEBS Lett; 1982 Aug; 144(2):195-8. PubMed ID: 6981526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.